In shockingly obvious proportions, phychiatric drugs are being favored upon most in studies conducted by their manufacturer, versus non-associated companies or competing industries. Although there is no legitimate proof that the companies are weighting their studies in their favor, the numbers are highly suspicious. As a generalized ratio, eight of ten studies conducted by the drug manufacturer will show positive results, while only five of ten same such studies conducted by outside sources would show positive results for the same drug, and only three of ten studies would show positive results for the drug from competing drug manufacturers.
This could mean dramatic loss of taxpayers money as sources such as Medicare dish out your dollars to pay for psychiatric drugs. While the industries do tend to push for the best drugs available, as the better drugs would obviously have the better test results, there is still some speculation as to the credibility of these contradictory scores. Is it safe to put our trust and our funds in medication which is potentially favored based on manufacturer bias instead of scientific data?
